HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 386 filers reported holding HALOZYME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.45 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $384,896 | +2.1% | 10,223 | 0.0% | 0.00% | 0.0% |
| Q2 2023 | $377,024 | -22.5% | 10,223 | -19.8% | 0.00% | 0.0% |
| Q1 2023 | $486,655 | -35.9% | 12,743 | -4.5% | 0.00% | 0.0% |
| Q4 2022 | $759,559 | +69.2% | 13,349 | +17.5% | 0.00% | 0.0% |
| Q3 2022 | $449,000 | -83.6% | 11,362 | -81.7% | 0.00% | -75.0% |
| Q2 2022 | $2,739,000 | -10.6% | 62,256 | -19.0% | 0.00% | 0.0% |
| Q1 2022 | $3,065,000 | -5.4% | 76,860 | -4.6% | 0.00% | 0.0% |
| Q4 2021 | $3,240,000 | -1.8% | 80,579 | -0.6% | 0.00% | -20.0% |
| Q3 2021 | $3,299,000 | +174.7% | 81,089 | +206.7% | 0.01% | +150.0% |
| Q2 2021 | $1,201,000 | +33.0% | 26,437 | +22.0% | 0.00% | +100.0% |
| Q1 2021 | $903,000 | +100.7% | 21,667 | +26.6% | 0.00% | 0.0% |
| Q3 2020 | $450,000 | -39.9% | 17,120 | -38.7% | 0.00% | -50.0% |
| Q2 2020 | $749,000 | -0.9% | 27,942 | -33.5% | 0.00% | 0.0% |
| Q1 2020 | $756,000 | +261.7% | 42,018 | +255.8% | 0.00% | +100.0% |
| Q4 2019 | $209,000 | -27.7% | 11,810 | -29.8% | 0.00% | 0.0% |
| Q2 2019 | $289,000 | +6.6% | 16,820 | 0.0% | 0.00% | 0.0% |
| Q1 2019 | $271,000 | – | 16,820 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 19,829,337 | $266,308,000 | 10.60% |
| BB BIOTECH AG | 6,929,832 | $93,068,000 | 2.95% |
| SECTORAL ASSET MANAGEMENT INC | 2,671,051 | $35,872,000 | 1.64% |
| Sterling Global Strategies LLC | 22,000 | $295,000 | 1.63% |
| Lombard Odier Asset Management (USA) Corp | 1,061,547 | $14,257,000 | 1.24% |
| PYRRHO CAPITAL MANAGEMENT, LP | 90,000 | $1,209,000 | 1.04% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 8,184,003 | $109,911,000 | 0.93% |
| Bellevue Asset Management AG | 246,000 | $3,304,000 | 0.54% |
| Convergence Investment Partners, LLC | 251,748 | $3,381,000 | 0.39% |
| Rhenman & Partners Asset Management AB | 172,000 | $2,310,000 | 0.37% |